Blog

Jan 18, 2025, 06:34

Intermittent versus continuous chemotherapy in advanced colorectal cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:

“Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial – Annals of Oncology

Authors: R. Labianca, A. Sobrero, L. Isa, E. Cortesi, S. Barni, D. Nicolella, M. Aglietta, S. Lonardi, D. Corsi, D. Turci, G.D. Beretta, G. Fornarini, E. Dapretto, I. Floriani, A. Zaniboni.

Intermittent FOLFIRI given on a 2 month on-off schedule doesn’t compromise PFS and OS in advanced colon cancer.”

A. Sobrero A. Zaniboni Akhil Santhosh cancer D. Corsi D. Nicolella D. Turci E. Cortesi E. Dapretto G. Fornarini G.D. Beretta I. Floriani L. Isa M. Aglietta OncoDaily Oncology R. Labianca S. Barni S. Lonardi

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage